Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
A.S.V. (ASV) | Roth Capital Partners | $36.00 | n.a. | |||
Forum Merger (FMCIU) (u) | EarlyBirdCapital | 12.50 | $10.00 | $10.00 | $125.00 | n.a. |
WideOpenWest (WOW) | UBS Investment Bank/ Credit Suisse | $100.00 | n.a. | |||
n.a. (not available) | ||||||
u (unit offering) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
Lumena Pharmaceuticals (LIVR) | Citigroup/ Cowen and Company/ Leerink Partners | $75.00 | ||||
New Terms | ||||||
Schneider National (SNDR) | Morgan Stanley/ UBS Investment Bank/ BofA Merrill Lynch | 28.95 | $18.00 | $20.00 | $549.99 | S/O |
Silver Run Acquisition Corp II (SRUNU) (u) | Citigroup/ Credit Suisse/ Deutsche Bank Securities | 90.00 | $10.00 | $10.00 | $900.00 | 1-Star |
Vantage Energy Acquisition (VEACU) (u) | Citigroup/ Credit Suisse/ Goldman, Sachs | 40.00 | $10.00 | $10.00 | $400.00 | S/O |
S/O (Subscribers Only) | ||||||
u (unit offering) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of March 20, 2017 | Manager(s) | Offered | Raised | Price | 3/24/17 | Change |
Alteryx (AYX) | Goldman, Sachs/ J.P. Morgan | 9.00 | $126.00 | $14.00 | $15.50 | 10.71% |
Silver Run Acquisition Corp II (SRUNU) (u) | Citigroup/ Credit Suisse/ Deutsche Bank Securities | 90.00 | $900.00 | $10.00 | $10.21 | 2.10% |